Home LiteratureArticle Details
PMID: 2787381 Published · ppublish English Journal Article

Activation of natural killer cells via the p75 interleukin 2 receptor.

The Journal of experimental medicine ·Vol. 170 ·No. 1 ·1989-07-01 ·Pages 291-6

Phillips JH, Takeshita T, Sugamura K, Lanier LL

Abstract

The IL-2R is composed of at least two subunits, the p55 (CD25/Tac) and p75 glycoproteins. The p75 IL-2R is expressed preferentially on resting human peripheral blood NK cells, but is not detected on substantial proportions of T and B lymphocytes, monocytes, or granulocytes. Anti-p75 IL-2R mAb substantially inhibits the early events associated with NK cell activation by IL-2, including inhibition of cytotoxic activity and induction of the CD69 early activation antigen. While anti-p55 IL-2R mAb alone failed to substantially inhibit the initial events of IL-2 stimulation, maximal inhibition of IL-2-induced cytotoxicity and proliferation was achieved by combining both anti-p55 IL-2R and anti-p75 IL-2R. Collectively, results from the present studies directly implicate the p75 IL-2R as the structure predominantly responsible for IL-2 activation of NK cells.

MeSH Terms
Antibodies, Monoclonal Antigen-Antibody Complex/analysis Cells, Cultured Humans Killer Cells, Natural/immunology Kinetics Lymphocyte Activation Receptors, Interleukin-2/biosynthesis,immunology
Chemicals
Antibodies, Monoclonal Antigen-Antibody Complex Receptors, Interleukin-2
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Phillips J H
Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043.
Takeshita T
Sugamura K
Lanier L L
References (17)
17 references, click to expand
  1. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5394-8 PMID: 3110786
  2. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex.
    Proc Natl Acad Sci U S A. 1987 Jun;84(12):4215-8 PMID: 3108887
  3. Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7246-50 PMID: 2444977
  4. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.
    J Clin Oncol. 1987 Dec;5(12):1933-41 PMID: 3500280
  5. The interleukin 2 receptor.
    Adv Immunol. 1988;42:165-79 PMID: 3129919
  6. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.
    J Exp Med. 1988 May 1;167(5):1572-85 PMID: 3259252
  7. Possible association between IL-2 receptors and class I HLA molecules on T cells.
    J Immunol. 1988 Nov 15;141(10):3512-5 PMID: 3263428
  8. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.
    J Exp Med. 1989 Apr 1;169(4):1323-32 PMID: 2784485
  9. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    J Immunol. 1983 Oct;131(4):1789-96 PMID: 6225799
  10. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  11. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    J Immunol. 1985 Feb;134(2):794-801 PMID: 3871216
  12. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
    J Exp Med. 1986 Sep 1;164(3):814-25 PMID: 3489062
  13. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
    J Immunol. 1986 Dec 15;137(12):3845-54 PMID: 3491151
  14. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
    J Exp Med. 1987 Jan 1;165(1):223-38 PMID: 3098894
  15. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9694-8 PMID: 3099289
  16. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.
    Proc Natl Acad Sci U S A. 1987 Apr;84(7):2002-6 PMID: 3031660
  17. The interleukin 2 receptor. Functional consequences of its bimolecular structure.
    J Exp Med. 1987 Oct 1;166(4):1055-69 PMID: 3116143
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-07-01
Pages
291-6
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189366
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]